Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07136415) titled 'Comparing Digital Therapy, Trazodone, and Daridorexant for Menopause-Related Insomnia Symptoms' on Aug. 8.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).
Primary Sponsor: Brigham and Women's Hospital
Condition:
Menopausal Women
Insomnia
Intervention:
Behavioral: Cognitive behavioral therapy for insomnia (CBT-i)
Drug: Trazodone
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: December 1, 2025
Target Sample Size: 1000
Countries of Recruitment:
United State...